> Back to EJC

2016 editions

  • December 2016
    Joao Incio on mechanisms to explain why obesity promotes cancer.
  • November 2016
    Mike Stratton on how mutational changes in a cancer genome can point to the cause of the cancer.
  • October 2016
    Ruth Muschel on a new target for treatments for colorectal cancer.
  • September 2016
    Freddie Hamdy on the effectiveness of treatments for prostate cancer.
  • August 2016
    Moshe Oren discusses the effects of the microenvironment on cancer cells.
  • July 2016
    Richard Gilbertson on the 'bad luck hypothesis' for the cause of cancer.
  • June 2016
    Key advances in clinical trials.
  • May 2016
    Mark Lemmon on the underlying biochemistry of cancer.
  • April 2016
    Roger Stupp on using alternating electric fields as treatment.
  • March 2016
    Charlotte Vrinten on public perception of deaths from cancer.
  • February 2016
    Guillermo Garcia-Manero on myelodysplastic syndromes (MDS).
  • December 2015/January 2016
    Nazneen Rahman on germline genetic screening in ovarian cancer.

> All 2015 Editions

> All 2014 Editions

> All 2013 Editions

> All 2012 Editions

> All 2011 Editions

EJC News Focus – May 2012

Loading EJC News Focus video

First International Consensus Guidelines for Advanced Breast Cancer

Advances in the treatment of early breast cancer have revolutionised the outlook for many patients. But an important minority – around one in three – still progress to the advanced stage, which is treatable, but almost never curable. Women and men with advanced breast cancer have an illness associated with significant symptoms and one for which, in contrast to the early setting, there are few recognised therapeutic standards. An international, multidisciplinary group has now produced the first consensus guidelines, and they were presented at the European Breast Cancer Conference (Vienna, Austria; 21-24 March 2012).

Lead author Fatima Cardoso (Champalimaud Cancer Center, Lisbon, Portugal) explains why she strongly believes that widespread implementation of these guidelines will lead to better survival outcomes in advanced breast cancer.

1st International consensus guidelines for advanced breast cancer (ABC1)
doi: 10.1016/j.breast.2012.03.003